Agenus
AGEN
#8237
Rank
C$0.49 B
Marketcap
C$10.98
Share price
8.73%
Change (1 day)
81.85%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): C$0.16 Billion

According to Agenus 's latest financial reports the company's current earnings are C$0.12 Billion. In 2025 the company made an earning of C$72.97 Million, an increase over its 2024 earnings that were of -C$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.16 B128.69%
2025 C$72.97 M-145.52%
2024 -C$0.17 Billion-28.13%
2023 -C$0.23 Billion-5.5%
2022 -C$0.24 Billion-556.26%
2021 C$51.72 M-130.37%
2020 -C$0.18 Billion73.75%
2019 -C$98.03 Million-48.74%
2018 -C$0.2 Billion34.32%
2017 -C$0.15 Billion-7.16%
2016 -C$0.16 Billion26.55%
2015 -C$0.13 Billion110.24%
2014 -C$57.65 Million49.12%
2013 -C$38.66 Million
2011 -C$26.69 Million-12.25%
2010 -C$30.42 Million-21.41%
2009 -C$38.71 Million-26.86%
2008 -C$52.92 Million13.72%
2007 -C$46.53 Million-33.4%
2006 -C$69.87 Million-31.84%
2005 -C$0.11 Billion9.74%
2004 -C$93.4 Million-0.8%
2003 -C$94.16 Million17.37%
2002 -C$80.23 Million37.83%
2001 -C$58.21 Million55.99%
2000 -C$37.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.32 B 21,614.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.38 B 10,892.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.41 B 7,921.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$13.99 B 8,267.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-C$0.44 Billion-358.33%๐Ÿ‡บ๐Ÿ‡ธ USA